Search results
Results From The WOW.Com Content Network
AstraZeneca's primary listing is on the London Stock Exchange and is a constituent of the FTSE 100 Index; it also has a secondary listing on the Nasdaq Stockholm. It is also listed on the American Nasdaq and is a Nasdaq-100 company. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide. [11]
Price Action: AZN stock is down 4.44% at $76.16 during the premarket session at last check on Thursday. Read Next: AstraZeneca’s COVID-19 Prevention Drug For Patients With Weak Immune Systems ...
Shares of AstraZeneca (NASDAQ: AZN) were sliding 3.2% lower as of 10:57 a.m. ET on Thursday. The decline came after the British drugmaker announced its second-quarter results. AstraZeneca reported ...
AstraZeneca increased its interim dividend by 7 cents to $1. ($1 = 0.7766 pounds) (Reporting by Pushkala Aripaka in Bengaluru and Maggie Fick in London; Editing by Sonia Cheema and Elaine Hardcastle)
On Tuesday, AstraZeneca Plc (NASDAQ:AZN) said the survival results did not reach statistical significance in the overall trial population in the TROPION-Lung01 phase 3 trial. Topline overall ...
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases . Its products include eculizumab (Soliris) and ravulizumab (Ultomiris), both used to treat the rare disorders of atypical hemolytic ...
For premium support please call: 800-290-4726 more ways to reach us
AstraZeneca's stock is up following its latest earnings report Thursday after the company reported $12.7 billion in revenue, beating consensus estimates of $11.8 billion in the first quarter of 2024.